These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 19769079)

  • 1. [Highly active antiretroviral therapy].
    Jablonowski H
    MMW Fortschr Med; 2009 Apr; 151(18):58-61. PubMed ID: 19769079
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term trends in adherence to antiretroviral therapy from start of HAART.
    Cambiano V; Lampe FC; Rodger AJ; Smith CJ; Geretti AM; Lodwick RK; Puradiredja DI; Johnson M; Swaden L; Phillips AN
    AIDS; 2010 May; 24(8):1153-62. PubMed ID: 20299959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [How HIV treatment can be simplified. "Once daily" as starter therapy is effective].
    Wepner U
    MMW Fortschr Med; 2009 Apr; 151(18):80-1. PubMed ID: 19769085
    [No Abstract]   [Full Text] [Related]  

  • 4. Parallel evolutions of the growth rate of newly diagnosed HIV cases and the proportion of potentially infective patients in Cayenne French Guiana: should HAART be used to curb the epidemic?
    Nacher M; Vantilcke V; Huber F; El Guedj M; Vaz T; Magnien C; Djossou F; Mahamat A; Dabis F; Couppié P
    Public Health; 2009 Aug; 123(8):573-4. PubMed ID: 19692100
    [No Abstract]   [Full Text] [Related]  

  • 5. Issues in antiretroviral therapy: when to start?
    Boyle BA
    AIDS Read; 2001 Feb; 11(2):66-70. PubMed ID: 11279874
    [No Abstract]   [Full Text] [Related]  

  • 6. Brazilian HIV-infected population: assessment of the needs of endodontic treatment in the post-highly active antiretroviral therapy era.
    de Brito LC; da Rosa MA; Lopes VS; e Ferreira EF; Vieira LQ; Sobrinho AP
    J Endod; 2009 Sep; 35(9):1178-81. PubMed ID: 19720212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between genotypic sensitivity score and treatment outcomes in late stage HIV disease after supervised HAART.
    Castor D; Vlahov D; Hoover DR; Berkman A; Wu YF; Zeller B; Brechtl J; Hammer SM
    J Med Virol; 2009 Aug; 81(8):1323-35. PubMed ID: 19551816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Earlier initiation of highly active antiretroviral therapy does not protect against the deleterious effects of non-adherence.
    Wood E; Hogg RS; Yip B; Harrigan PR; Montaner JS
    AIDS; 2004 Dec; 18(18):2432-4. PubMed ID: 15622322
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of anger in adherence to highly active antiretroviral treatment in patients infected with HIV.
    Leombruni P; Fassino S; Lavagnino L; Orofino G; Morosini P; Picardi A
    Psychother Psychosom; 2009; 78(4):254-7. PubMed ID: 19468260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Resistance screening].
    Sierra S; Lengauer T; Kaiser R
    MMW Fortschr Med; 2009 Apr; 151(18):72, 74-5. PubMed ID: 19769083
    [No Abstract]   [Full Text] [Related]  

  • 11. The public health implications of HIV therapy.
    Ritsema TS
    JAAPA; 2002 Apr; 15(4):29-30, 33-4, 39. PubMed ID: 12012585
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-HIV agents. Should HAART begin right after an HIV diagnosis?
    TreatmentUpdate; 2009; 21(3):2-3. PubMed ID: 19630120
    [No Abstract]   [Full Text] [Related]  

  • 13. Pseudo-primary infection syndrome following discontinuation of antiretroviral therapy.
    Zeller V; Charlois C; Duvivier C; Bricaire F; Katlama C
    Antivir Ther; 2001 Sep; 6(3):191-3. PubMed ID: 11808754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sexual dysfunction and HAART.
    TreatmentUpdate; 2001 Aug; 13(4):5-7. PubMed ID: 11590980
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of acute HIV-1 infection: is it coming of age?
    Kinloch-de Loes S
    J Infect Dis; 2006 Sep; 194(6):721-4. PubMed ID: 16941336
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of multidrug resistant primary HIV infection with delayed CD4 T-cell count decline despite low viral load, treated with interleukin-2.
    Pao D; Smit E; Imami N; Fisher M
    AIDS; 2006 Jul; 20(11):1564-5. PubMed ID: 16847417
    [No Abstract]   [Full Text] [Related]  

  • 17. Continue antiretroviral therapy during virologic failure?
    Smith D; Wong J
    Clin Infect Dis; 2002 Feb; 34(4):553-6. PubMed ID: 11797186
    [No Abstract]   [Full Text] [Related]  

  • 18. Nutrition. Study finds vitamin B12 levels low in some HAART users.
    TreatmentUpdate; 2003 Oct; 15(6):6-7. PubMed ID: 17216864
    [No Abstract]   [Full Text] [Related]  

  • 19. Vertebral fractures in AIDS patients within 6 months from highly active antiretroviral therapy initiation: two case reports.
    Gazzola L; Bini T; Pietrogrande L; Uziel L; Cicconi P; Casana M; Monforte Ad
    AIDS; 2008 May; 22(9):1094-7. PubMed ID: 18520358
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-HIV agents. Questions about the early and aggressive use of therapy.
    TreatmentUpdate; 2000 Mar; 12(2):2-4. PubMed ID: 12125618
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.